Role of Endogenous Androgen Against Insulin Resistance and Athero-sclerosis in Men with Type 2 Diabetes
Journal:
Current Diabetes Reviews
Volume:
3
Page:
25-31
Author(s):
Michiaki Fukui, Yoshihiro Kitagawa, Hiroyuki Ose, Goji Hasegawa, Toshikazu Yoshikawa and Naoto Nakamura
Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus
Journal:
Current Diabetes Reviews
Volume:
3
Page:
33-39
Author(s):
Mollie A. Jay and Jun Ren
Cardiac and Metabolic Consequences of Aerobic Exercise Training in Experimental Diabetes
Journal:
Current Diabetes Reviews
Volume:
3
Page:
75-84
Author(s):
Christine Saraceni and Tom L. Broderick
Therapeutic Opportunities for Trophic Factors in Brain Inflammation
Journal:
Current Pharmaceutical Analysis
Volume:
3
Page:
7-15
Author(s):
Beatriz Moreno and Pablo Villoslada
Lipid Disorders in Diabetes Mellitus and Current Management
Journal:
Current Pharmaceutical Analysis
Volume:
3
Page:
17-24
Author(s):
Garry X. Shen
The Role of Myocardial Collagen Network in Hypertensive Heart Disease
Journal:
Current Hypertension Reviews
Volume:
3
Page:
1-7
Author(s):
Javier Diez, Begona Lopez, Arantxa Gonzalez and Ramon Querejeta
Are Calcium Channel Blockers First-Line Drugs for the Treatment of Hypertension and Cardiovascular Disease?
Journal:
Current Hypertension Reviews
Volume:
3
Page:
9-13
Author(s):
Alejandro de la Sierra and Luis Miguel Ruilope
Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?
Journal:
Current Hypertension Reviews
Volume:
3
Page:
15-20
Author(s):
Michel Burnier, Roberto Bullani and Bruno Vogt
Beta-Blockers as First Line Treatment of Hypertension: A Proponents View
Journal:
Current Hypertension Reviews
Volume:
3
Page:
21-28
Author(s):
Steven G. Chrysant
Insights into the Relationship Between Hypertension and Albuminuria
Journal:
Current Hypertension Reviews
Volume:
3
Page:
29-37
Author(s):
Lucinda M. Hilliard, Leileata M. Russo and Wayne D. Comper